Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000135

Type of data
NGS (CAGE-seq)
Sanger sequencing
Access criteria
Controlled-access (Type I)
Total data volume
5.8 GB
File formats
  • FASTQ
  • FASTA
Research
hum0118
Date published
2020-09-28
Date modified
2020-11-18
DDBJ Search
JGAD000135 (opens in a new tab)
JGA Study
JGAS000124 (opens in a new tab)

Analysis method

CAGE-seq

Materials and participants
15 endometrial cancer patients (ICD10: C54.1)
  • Health status
    Affected
  • Subject count
    15 (Sample)
Disease
endometrial cancer patients (C541)
Sample description
RNA extracted from surgically dissected tumor tissues
  • Tissue
    Endometrium
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
CAGE-seq
Target
N/A
Fragmentation
N/A
Platform
Illumina HiSeq 2500
Read type
Single-end
Read length
47 bp
Data use policy
NBDC data sharing policy (JGAP000001)

Sanger sequencing

Materials and participants
3 endometrial cancer patients (ICD10: C54.1)
  • Health status
    Affected
  • Subject count
    3 (Sample)
Disease
endometrial cancer patients (C541)
Sample description
cDNA synthesize from RNA extracted from surgically dissected tumor tissues
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
Sanger sequencing
Target
TACC2(chr10:123,748,689-124,014,057 [ref: hg19])
Reagent kit
BigDye Terminator v3.1 Cycle Sequencing Kit
Platform
Thermo Fisher Scientific 3500 Genetic Analyzer
Reference genome
GRCh37
Data use policy
NBDC data sharing policy (JGAP000001)